Late gadolinium enhancement CMR in primary mitral regurgitation

European Journal of Clinical Investigation

Volumn 44, Issue 9, 2014, Pages 840-847

  Van De Heyning, Caroline M ^a,b   Magne, Julien ^a   Piérard, Luc A ^a   Bruyère, Pierre Julien ^a   Davin, Laurent ^a   De Maeyer, Catherine ^b   Paelinck, Bernard P ^b   Vrints, Christiaan J ^b   Lancellotti, Patrizio ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiac magnetic resonance; Echocardiography; Fibrosis; Mitral regurgitation; Valve

Indexed keywords

CONTRAST MEDIUM; GADOBUTROL; ORGANOMETALLIC COMPOUND;

CLINICAL TRIAL; DIAGNOSTIC USE; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART VENTRICLE REMODELING; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY;

CONTRAST MEDIA; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; VENTRICULAR REMODELING;

EID: 84906739313     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12306     Document Type: Article

References (34)

1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.
2. Itagaki S, Adams DH, Anyanwu AC. Triggers for surgical referral in degenerative mitral valve regurgitation. Circ J 2012;77:28-34.
3. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
4. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830-7.
5. Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 2009;54:1961-8.
6. Barbieri A, Bursi F, Grigioni F, Tribouilloy C, Avierinos JF, Michelena HI et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a Multicenter Long-term International Study (on behalf of the Mitral Regurgitation International DAtabase (MIDA) Investigators). Eur Heart J 2011;32:751-9.
7. Le Tourneau T, Richardson M, Juthier F, Modine T, Fayad G, Polge AS et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 2010;96:1311-7.
8. Le Tourneau T, Messika-Zeitoun D, Russo A, Detaint D, Topilsky Y, Mahoney DW et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 2010;56:570-8.
9. Rusinaru D, Tribouilloy C, Grigioni F, Avierinos JF, Suri RM, Barbieri A et al. Left atrial size is a potent predictor of mortality in mitral regurgitation due to flail leaflets: results from a large international multicenter study. Circ Cardiovasc Imaging 2011;4:473-81.
10. Messika-Zeitoun D, Johnson BD, Nkomo V, Avierinos JF, Allison TG, Scott C et al. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J Am Coll Cardiol 2006;47:2521-7.
11. Lancellotti P, Cosyns B, Zacharakis D, Attena E, Van Camp G, Gach O et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr 2008;21:1331-6.
12. Magne J, Lancellotti P, Piérard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010;122:33-41.
13. Pizarro R, Bazzino OO, Oberti PF, Falconi M, Achilli F, Arias A et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol 2009;54:1099-106.
14. Magne J, Mahjoub H, Pierard LA, O'Connor K, Pirlet C, Pibarot P et al. Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation. Heart 2012;98:584-91.
15. Magne J, Mahjoub H, Pibarot P, Pirlet C, Pierard LA, Lancellotti P. Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation. Eur J Heart Fail 2012;14:1293-302.
16. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011;58:1271-9.
17. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85.
18. Cheong B, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 2009;120:2069-76.
19. Han Y, Peters DC, Salton CJ, Bzymek D, Nezafat R, Goddu B et al. Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging 2008;1:294-303.
20. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
22. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611-44.
23. Schiros CG, Dell'Italia LJ, Gladden JD, Clark D, Aban I, Gupta H et al. Magnetic resonance imaging with 3-dimensional analysis of left ventricular remodeling in isolated mitral regurgitation: implications beyond dimensions. Circulation 2012;125:2334-42.
24. Brower GL, Chancey AL, Thanigaraj S, Matsubara BB, Janicki JS. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol 2002;283:H518-25.
25. Stewart JA, Wei CC, Brower GL, Rynders PE, Hankes GH, Dillon AR et al. Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J Mol Cell Cardiol 2003;35:311-9.
26. Wang BW, Wu GJ, Cheng WP, Shyu KG. MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart. PLoS ONE 2014;9:e84188.
27. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2008;52:e1-142.
28. Hanna N, Cardin S, Leung TK, Nattel S. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 2004;63:236-44.
29. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.
30. Sidhu M, Chan AK, Chockalingam A, Dresser T. Myocardial perfusion imaging analysis in patients with regurgitant valvular heart disease. J Nucl Cardiol 2011;18:309-13.
31. Kramer CM. Cardiac magnetic resonance imaging identification of myocardial fibrosis: the need for standardization and therapies. J Am Coll Cardiol 2010;56:288-9.
32. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 2013;6:373-83.
33. Chin CW, Semple S, Malley T, White AC, Mirsadraee S, Weale PJ et al. Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging 2014;15:556-65.
34. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52:1574-80.